In vitro characterization of immune modulating drug-eluting immunobeads towards transarterial embolization in cancer

In vitro characterization of immune modulating drug-eluting immunobeads towards transarterial embolization in cancer

Abstract Hepatocellular carcinoma (HCC) is an aggressive liver cancer with limited effective treatment options. In this study, we selected TLR agonists imiquimod (IMQ), gardiquimod (GARD), GS-9620 and DSR 6434, and a small molecule checkpoint inhibitor, BMS-202, for characterization of drug loading...

Full description

Bibliographic Details
Main Authors: Ayele H. Negussie, Andrew S. Mikhail, Joshua W. Owen, Natalie Hong, Camella J. Carlson, Yiqing Tang, Kendal Paige Carrow, Michal Mauda-Havakuk, Andrew L. Lewis, John W. Karanian, William F. Pritchard, Bradford J. Wood
Format: Article
Language:English
Published: Nature Portfolio 2022-12-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-26094-1

Internet

https://doi.org/10.1038/s41598-022-26094-1

Similar Items